The impact of board gender diversity on healthcare financial performance during Covid- 19: Evidence from Italian Healthcare Organizations

Titolo Rivista MANAGEMENT CONTROL
Autori/Curatori Nadia Ardito, Natalia Aversano, Diana Ferullo, Paolo Tartaglia Polcini
Anno di pubblicazione 2024 Fascicolo 2024/2 Suppl.
Lingua Inglese Numero pagine 23 P. 223-245 Dimensione file 254 KB
DOI 10.3280/MACO2024-002-S1011
Il DOI è il codice a barre della proprietà intellettuale: per saperne di più clicca qui

Anteprima articolo

FrancoAngeli è membro della Publishers International Linking Association, Inc (PILA)associazione indipendente e non profit per facilitare (attraverso i servizi tecnologici implementati da CrossRef.org) l’accesso degli studiosi ai contenuti digitali nelle pubblicazioni professionali e scientifiche

Over the past few decades, European institutions and policymakers have promot-ed gender diversity in management and strategic leadership roles. Prior literature has highlighted the importance of board gender diversity; neverthe-less, previous studies have mainly focused on the private sector, while the public sector – particularly the healthcare sector – remains under-investigated. Hence, to fill this gap, the present paper aims to examine the impact of board gen-der diversity on Italian public health outcomes during the COVID-19 pandemic to address the calls for more excellent representation of women in leadership roles. The research methodology uses an OLS linear regression model to examine the re-lationship between the number of women in top positions in Italian Healthcare Or-ganizations (roles of general, administrative, and health managers) and their fi-nancial and non-financial performance. Results show that women’s involvement in governance positively impacts the per-formance of Italian healthcare organisations, while no significant association has emerged regarding non-financial performance. This study could represent a starting point for implementing measures that focus on the health sector. The sector has been experiencing a severe crisis for years and, therefore, needs innovative strategies for its relaunch.

Keywords:Board Gender Diversity, Public Healthcare Organizations, Financial Performance, Non-financial Performance, Italy, COVID-19.

  1. Abor P.A. (2017), Examining gender diversity on hospital boards in Ghana, International Journal of Health Governance, 22(4), pp. 269-282. DOI: 10.1108/IJHG-04-2017-0016
  2. Andrades-Peña F.J., Larrán M., Muriel M.J., Calzado M.Y., Lechuga Sancho M.P. (2021), Online sustainability disclosure by Spanish hospitals: an institutionalist approach, International Journal of Public Sector Management, 34(5), pp. 529-545. DOI: 10.1108/IJPSM-09-2020-0259
  3. Anessi-Pessina E., Cantù E. (2017), Multiple logics and accounting mutations in the Italian National Health Service., Accounting Forum, 41(1), pp. 8-27.
  4. Arena C., Catuogno S., Saggese S., Sarto F. (2019), Gender Diversity in Public Hospitals’ TMT: The Impact on Financial and Non-Financial Performance, in: ICGR 2019 2nd International Conference on Gender Research, April, pp. 43-50, 2019, X, XIII, XXII. Reading: Academic Conferences International Limited.
  5. Aversano N., Nicolò G., Ferullo D., Polcini P. T. (2023), The effect of board gender diversity on financial and non-financial performance: evidence from Italian public universities, Public Money & Management, 43(7), pp. 679-688.
  6. Aversano N., Ferullo D., Nicolò G., Ardito N. (2024), Performance reporting in the healthcare sector: evidence from Italian healthcare organisations, International Journal of Productivity and Performance Management, 73(4), pp. 1117-1136.
  7. Betto F., Sardi A., Garengo P., Sorano E. (2022), The Evolution of Balanced Scorecard in Healthcare: A Systematic Review of Its Design, Implementation, Use, and Review, International Journal of Environmental Research and Public Health. 19(16), 10291.
  8. Borgonovi E., Catuogno S. (2021), Diversità di genere, leadership e performance nelle aziende di tutela della salute, Mecosan, 120, pp. 3-6. DOI: 10.3280/MESA2021-120001
  9. Brenna E., Spandonaro F. (2015), Regional incentives and patient cross-border mobility: evidence from the Italian experience, International Journal of Health Policy and Management, 4(6), p. 363.
  10. Brennan N. M. (2021), Connecting earnings management to the real world: What happens in the black box of the boardroom?, The British Accounting Review, 53(6), 101036.
  11. Büchner V.A., Schreyögg J., Schultz C. (2014), The impact of the board’s strategy-setting role on board-management relations and hospital performance, Health Care Management Review, 39(4), pp. 305-317.
  12. Capalbo F., Sorrentino M., Smarra M., Ippolito A. (2023), Il ruolo strategico dei Sistemi di Misurazione delle Performance nelle aziende sanitarie: un caso studio, Management Control, 1, pp. 119-142. DOI: 10.3280/MACO2023-001006
  13. Cavicchi C., Vagnoni E. (2017), Does intellectual capital promote the shift of healthcare organisations towards sustainable development? Evidence from Italy, Journal of Cleaner Production, 153, pp. 275-286.
  14. Chang L.C. (2006), Managerial responses to externally imposed performance measurement in the NHS: an institutional theory perspective, Financial accountability & management, 22(1), pp. 63-85.
  15. Cifalinò A., Vendramini E. (2015), La diffusione e l’utilizzo delle misure di performance dei servizi di assistenza primaria nel SSN, Economia Aziendale Online, 6(2), pp. 63-77. DOI: 10.6092/2038-5498/6.2.63-77
  16. Cinelli G., Meda F., Gugiatti A. (2021), La struttura e le attività del SSN, in: Rapporto OASI 2021, Milano, Egea, pp. 37-115.
  17. Cinquini L., Nuti S., Boccaccio A., Vainieri M. (2005), Il confronto di performance economico-finanziarie tra aziende sanitarie: l’esperienza della Regione Toscana, Mecosan, 14, p. 54.
  18. De Regge M., Eeckloo K. (2020), Balancing hospital governance: A systematic review of 15 years of empirical research, Social Science & Medicine, 262, 113252.
  19. El Chaarani H., Raimi L. (2022). Diversity, entrepreneurial innovation, and performance of healthcare sector in the COVID‐19 pandemic period, Journal of Public Affairs, 22, e2808.
  20. EU Commission (2020), A Union of Equality: Gender Equality Strategy 2020-2025, in Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions, Bruxelles, https://ec.europa.eu/info/policies/justice-and-fundamental-rights/gender-equality/gender-equality-strategy_en.
  21. Farrar D.E., Glauber R.R. (1967), Multicollinearity in regression analysis: the problem revisited, The Review of Economics and Statistics, 49(m1), pp. 92-107.
  22. Fissi S., Grazzini F. (2021), L’utilizzo dei Social Media durante la pandemia da COVID-19: un nuovo strumento per la gestione del rischio sanitario?, Management Control, suppl. 2, pp. 265-288. DOI: 10.3280/MACO2021-002-S1012
  23. Fusco A., Galeone G., Schimperna F., Lombardi R. (2021), The impact of Gender diversity on Healthcare System and Leadership: A first SLR for the future research, Mecosan, 120, pp. 7-19. DOI: 10.3280/MESA2021-120002
  24. Gartner J.B., Lemaire C. (2022), Dimensions of performance and related key performance indicators addressed in healthcare organisations: A literature review, The International Journal of Health Planning and Management, pp. 1-12.
  25. Gigio L.A., Alampi D., Camussi S., Ciaccio G., Guaitini P., Lozzi M., Mancini A.L., Panicara E., Paolicelli M. (2018), La sanità in Italia: il difficile equilibrio tra vincoli di bilancio e qualità dei servizi nelle regioni in piano di rientro, Banca d'Italia.
  26. Giuffrida A., Lapecorella F., Pignataro G. (2000), Organizzazione dell’assistenza ospedaliera: analisi dell’efficienza delle aziende ospedaliere e dei presidi ospedalieri, Economia Pubblica, XXX(4).
  27. Gurd, B., Gao, T. (2007), Lives in the balance: an analysis of the balanced scorecard (BSC) in healthcare organisations, International Journal of Productivity and Performance Management, 57(1), pp. 6-21.
  28. Hood C. (1995), The New Public Management in the 1980s: variations on a theme, Accounting, Organizations and Society, 20(2-3), pp. 93-109. DOI: 10.1016/0361-3682(93)E0001-W
  29. Leung T.Y., Sharma P., Adithipyangkul P., Hosie P. (2020), Gender equity and public health outcomes: The COVID-19 experience, Journal of Business Research, 116, pp. 193-198.
  30. Longo F., Ricci A. (2020), Le fratture generate dal Covid-19: quali priorità strategiche per la sanità italiana?, in: Rapporto OASI 2020, Milano, Egea, pp. 3-34.
  31. Lu J., Herremans I.M. (2019), Board gender diversity and environmental performance: An industries perspective, Business Strategy and the Environment, 28(7), pp. 1449-1464.
  32. Manes-Rossi F., Bisogno M., Aversano N., Citro F. (2020), Intellectual capital in Italian healthcare: senior managers’ perspectives, International Journal of Public Sector Management, 33(6/7), pp. 629-646. DOI: 10.1108/IJPSM-11-2019-0298
  33. Martínez-Córdoba P.J., Benito B., García-Sánchez I.M. (2021), Efficiency in the governance of the Covid-19 pandemic: political and territorial factors, Globalization and health, 17, pp. 1-13.
  34. Mertens W. (2017), Quantitative Data Analysis, Springer International Publishing.
  35. Naciti V., Noto G., Vermiglio C. (2021), Diversità di genere e performance organizzativa: un'analisi empirica nel settore sanitario, Mecosan, 120, pp. 45-61. DOI: 10.3280/MESA2021-120004
  36. Naranjo‐Gil D., Hartmann F., Maas V.S. (2008), Top management team heterogeneity, strategic change, and operational performance, British Journal of Management, 19(3), pp. 222-234,
  37. Nicolò G., Ferullo D., Aversano N., Ardito N. (2023), Intellectual capital disclosure and its determinants in healthcare organisations–Evidence from Italy, International Journal of Public Sector Management, 36(1), pp. 20-45.
  38. Nuti S., Seghieri C., Vainieri M. (2013), Assessing the effectiveness of a performance evaluation system in the public health care sector: some novel evidence from the Tuscany region experience, Journal of Management & Governance, 17(1), pp. 59-69.
  39. Paoloni P., Dal Mas F., Barcellini A., Orlandi E. (2021), Leadership femminile in sanità: possibili soluzioni e strumenti: un caso di studio, Mecosan, 120, pp. 83-104. DOI: 10.3280/MESA2021-120006
  40. Pavan A., Paglietti P., Reginato E., Fadda I. (2019), Corruzione e performance nei sistemi sanitari regionali italiani, Management Control, 3, pp. 123-146. DOI: 10.3280/MACO2019-003007
  41. Pfeffer J., Salancik G.R. (2003), The external control of organisations: A resource dependence perspective, Stanford University Press.
  42. Pizzi S., Caputo F., Venturelli A. (2021), Accounting to ensure healthy lives: a critical perspective from the Italian National Healthcare System, Corporate Governance, 20(3), pp. 445-460.
  43. Porcu R. (2007), Servizi sanitari, popolazione e mobilità sanitaria della Sardegna: un’analisi multiway, Difesa Sociale. Bisogni socio-sanitari, servizi e territorio, 3, pp. 57-74.
  44. Posteraro N. (2018), La compensazione ei rimborsi nella mobilità sanitaria interregionale e transfrontaliera, Il Diritto Dell'economia, 97(3), pp. 851-880.
  45. Purbey S., Mukherjee K., Bhar C. (2007), Performance measurement system for healthcare processes, International Journal of Productivity and Performance Management, 56(3) pp. 241-251. DOI: 10.1108/17410400710731446
  46. Rainero C., Brescia V., Cataldo A. (2019), La formazione manageriale in sanità. Nuovi strumenti e modelli tra governance e politiche, Economia Aziendale Online, 10(2), pp. 235-256. DOI: 10.13132/2038-5498/10.2.1936
  47. Reguera-Alvarado N., De Fuentes P., Laffarga J. (2017), Does board gender diversity influence financial performance? Evidence from Spain, Journal of Business Ethics, 141(2), pp. 337-350.
  48. Saporito R., Sartirana M., Tozzi V. (2019), La femminilizzazione dei ruoli apicali in sanità: dimensioni del fenomeno, cause e prospettive, in: Rapporto Oasi 2019, Milano, Egea, pp. 613-619.
  49. Sicoli G., Rija M. (2021), Diversità di genere e sistema sanitario: un’analisi su un campione di aziende sanitarie italiane, Mecosan, 120, pp. 63-81. DOI: 10.3280/MESA2021-120005
  50. Tartaglia Polcini P., Aversano N., Nicolò G., Ardito N. (2021), La diversità di genere nella direzione strategica delle aziende sanitarie: il rapporto tra governance e performance nelle aziende ospedaliere italiane, Mecosan, 120, pp. 21-43.
  51. UN (2015), Transforming our world: the 2030 agenda for sustainable development. United Nations General Assembly. New York, www.un.org/ga/search/view_doc.asp?symbol=A/ RES/70/1&Lang=E.
  52. UNDP (2020), Global Human Development Indicators, United Nations Development Programme Human Development Reports, New York, USA.
  53. Uyar A., Kilic M., Koseoglu M.A., Kuzey C., Karaman A.S. (2020), The link among board characteristics, corporate social responsibility performance, and financial performance: Evidence from the hospitality and tourism industry, Tourism Management Perspectives, 35, 100714.
  54. Voelker K. E., Rakich J. S., French G. R. (2001), The balanced scorecard in healthcare organisations: a performance measurement and strategic planning methodology, Hospital topics, 79(3), pp. 13-24.
  55. Van Daalen K.R., Bajnoczki C., Chowdhury M., Dada S., Khorsand P., Socha A., Lal A., Jung L., Alqodmani L., Torres I., Ouedraogo S., Mahmud A.J., Dhatt R., Phelan A., Rajan D. (2020), Symptoms of a broken system: the gender gaps in COVID-19 decision-making, BMJ global health, 5(10), e003549
  56. Villa A. (2011), Federalismo regionale: costi e fabbisogni standard nel settore sanitario, Giornale diritto Amministrativo, 938.
  57. Vinci S., D'Amico E., Biscotti A. M. (2022), I sistemi di management control nella sanità pubblica italiana: dalle strutture verticali ai processi orizzontali, Management Control, 1, pp. 103-119. DOI: 10.3280/MACO2022-001007
  58. Vrontis D., El Chaarani H., El Abiad Z., El Nemar S., Yassine Haddad A. (2022), Managerial innovative capabilities, competitive advantage and performance of healthcare sector during Covid-19 pandemic period, Foresight, 24(3/4), pp. 504-526.

Nadia Ardito, Natalia Aversano, Diana Ferullo, Paolo Tartaglia Polcini, The impact of board gender diversity on healthcare financial performance during Covid- 19: Evidence from Italian Healthcare Organizations in "MANAGEMENT CONTROL" 2 Suppl./2024, pp 223-245, DOI: 10.3280/MACO2024-002-S1011